This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Bailey, C. J. PubMed Articles by Bailey, C. J. Social Bookmarking                         What's this?

What are the practical implications for treating diabetes in light of recent evidence? Updated recommendations from the Global Partnership for Effective Diabetes Management

Aston University, Birmingham, UK, c.j.bailey{at}aston.ac.uk

Lawrence Blonde

Ochsner Medical Center, New Orleans, LA, USA

Stefano Del Prato

University of Pisa, Pisa, Italy

Lawrence A. Leiter

St Michael's Hospital and University of Toronto,Toronto, ON, Canada

Richard Nesto

Lahey Clinic, Burlington, MA, USA

Global Partnership for Effective Diabetes Management

The Global Partnership for Effective Diabetes Management was established in 2004 to provide practical guidance to improving glycaemic control for people with type 2 diabetes. Those recommendations have been updated to take account of recent trials assessing the effects of intensive glucose control. We continue to emphasis the importance of early and sustained glycaemic control, aiming for HbA _1c 6.5—7% wherever safe and appropriate. Individualisation of targets and the management process is strongly encouraged to accommodate patient circumstances and to avoid hypoglycaemia. Prompt introduction of combinations of agents is suggested when monotherapy is inadequate.Treatments will preferably address the underlying pathophysiology of type 2 diabetes and integrate within a wider programme of care which also aims to reduce modifiable cardiovascular risk factors and better equip patients in the self-management of their condition.

Key Words: Glycaemic control • HbA1C • type 2 diabetes • individualising treatment • risk management • integrated care • Global Partnership

Diabetes and Vascular Disease Research, Vol. 6, No. 4, 283-287 (2009)
DOI: 10.1177/1479164109341691


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?